Anti-EP4 Polyclonal Antibody

Anti-EP4 Polyclonal Antibody，非常适合开展WB和FCM实验类型。更多视频请关注视频号【艾维缔】。哔哩哔哩【IVDSHOW】。抖音【军哥聊表观】。

关键词

所属分类

精品一抗

目录号

TMAB-00621

获取报价

产品组分

内容	型号	规格	储存温度
Anti-EP4 Polyclonal Antibody	TMAB-00621-01	50uL	-20°C
Anti-EP4 Polyclonal Antibody	TMAB-00621-02	100uL	-20°C
Anti-EP4 Polyclonal Antibody	TMAB-00621-03	200uL	-20°C
操作手册	1	1	常温

文件资源

营销中心
注意事项

保存建议厂家推荐蓝冰运输。当您收到产品后，按照说明书建议保存于-20°C。
FAQ
Teramoto K et al. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy. Cancer Res. 63, 7920-5 (2003)(PMID:14633722)

Li W et al. Immunostimulating properties of intragastrically administered Acetobacter-derived soluble branched (1,4)-beta-D-glucans decrease murine susceptibility to Listeria monocytogenes. Infect Immun. 72, 7005-11 (2004)(PMID:15557623)

Yajima T et al. A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection. J Immunol. 174, 3590-7 (2005)(PMID:15749896)

Nabekura T et al. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. Mol Ther. 13, 301-9 (2006)(PMID:16311073)

Yajima T et al. IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol. 176, 507-15 (2006)(PMID:16365444)

Wakita D et al. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. Int Immunol. 18, 425-34 (2006)(PMID:16415100)

Yokouchi H et al. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer. Cancer Sci. 97, 148-54 (2006)(PMID:16441426)

Chamoto K et al. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Res. 66, 1809-17 (2006)(PMID:16452242)

Saito K et al. Impaired protection against Mycobacterium bovis bacillus Calmette-Guerin infection in IL-15-deficient mice. J Immunol. 176, 2496-504 (2006)(PMID:16456010)

Taneichi M et al. Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. J Immunol. 177, 2324-30 (2006)(PMID:16887993)

Zhang Y et al. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs. Int Immunol. 19, 151-61 (2007)(PMID:17189593)

Li W et al. Tyk2 signaling in host environment plays an important role in contraction of antigen-specific CD8+ T cells following a microbial infection. J Immunol. 178, 4482-8 (2007)(PMID:17372006)

Sugiyama T et al. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Int Immunol. 20, 1-9 (2008)(PMID:17981792)

Kumar H et al. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol. 180, 683-7 (2008)(PMID:18178804)

Wakabayashi A et al. Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin. J. Immunol. 180, 4000-10 (2008)(PMID:18322209)

Miyakoda M et al. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J Immunol. 181, 1420-8 (2008)(PMID:18606696)

Kijima M et al. Jagged1 suppresses collagen-induced arthritis by indirectly providing a negative signal in CD8+ T cells. J Immunol. 182, 3566-72 (2009)(PMID:19265135)

Tang C et al. IL-15 protects antigen-specific CD8+ T cell contraction after Mycobacterium bovis bacillus Calmette-Guérin infection. J Leukoc Biol. 86, 187-94 (2009)(PMID:19389797)

Senju S et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cell 27, 1021-31 (2009)(PMID:19415766)

Asano J et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J Immunol. 184, 736-45 (2010)(PMID:20008287)

Takeshima T et al. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 70, 2697-706 (2010)(PMID:20215523)

Kuwada E et al. Insoluble fraction of tumor cell homogenate is a useful material for eliciting cytotoxic T lymphocytes: a unique method for protein solubilization. Anticancer Res. 31, 881-91 (2011)(PMID:21498709)

Yanai H et al. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). PNAS. 108, 11542-7 (2011)(PMID:21709231)

Kurachi S et al. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration. J Exp Med. 208, 1605-20 (2011)(PMID:21788406)

Fukaya T et al. Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. PNAS. 109, 11288-93 (2012)(PMID:22736794)

Shimizu K et al. Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction. J Immunol. 190, 5609-5619 (2013)(PMID:23630347)

Yamada H et al. Positive selection of self-antigen-specific CD8+ T cells by hematopoietic cells. Eur J Immunol 43, 2033-42 (2013)(PMID:23636825)

Yamazaki C et al. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J Immunol. 190, 6071-6082 (2013)(PMID:23670193)

Kimura K et al. CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection. Infect Immun. 81, 3825-34 (2013)(PMID:23897612)

Kobiyama K et al. Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist. PNAS 111, 3086-91 (2014)(PMID:24516163)

Tsukamoto H et al. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression. Cancer Immunol Res. 1, 64-76 (2013)(PMID:24777249)

Ito M et al. Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity. PLoS One 9, e110425 (2014)(PMID:25343355)

Sawada Y et al. Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes. Int J Oncol. 46, 28-36 (2015)(PMID:25354479)

Toyota H et al. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo. Oncol Rep. 33, 292-6 (2015)(PMID:25394516)

Eikawa S et al. Immune-mediated antitumor effect by type 2 diabetes drug, metformin. PNAS. 112, 1809-14 (2015)(PMID:25624476)

Fu C et al. β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10. PNAS. 112, 2823-8 (2015)(PMID:25730849)

Hanson MC et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest. 125, 2532-46 (2015)(PMID:25938786)

Sasaki K et al. Thymoproteasomes produce unique peptide motifs for positive selection of CD8(+) T cells. Nat Commun. 6, 7484 (2015)(PMID:26099460)

Ito D et al. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells. J Immunol. 195, 934-43 (2015)(PMID:26116500)

Seregin SS et al. Dissecting CD8+ NKT Cell Responses to Listeria Infection Reveals a Component of Innate Resistance. J Immunol 195, 1112-20 (2015)(PMID:26116513)

Takada K et al. TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol. 16, 1069-76 (2015)(PMID:26301566)

Pearce VQ et al. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol 195, 3206-17 (2015)(PMID:26311905)

Kamimura D et al. Strong TCR-mediated signals suppress integrated stress responses induced by KDELR1 deficiency in naive T cells. Int Immunol. 28, 117-26 (2016)(PMID:26489882)

Rapaport AS et al. The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection. Immunity 43, 1112-24 (2015)(PMID:26680205)

Uto T et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 7, 11273 (2016)(PMID:27068492)

Takeda Y et al. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Canc Res. 35,143 (2016)(PMID:27619885)

Llopiz D et al. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget 8, 2659-2671 (2017)(PMID:27926522)

Ito M et al. Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells. PLoS One. 12, e0188934 (2017)(PMID:29190754)

Takahashi H et al. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides. Front Immunol. 9, 783 (2018)(PMID:29720976)

Takeda Y et al. Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models. Cancer Sci. 109, 2119-2129 (2018)(PMID:29791768)

Wakabayashi A et al. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA. Cell Death Dis. 9, 631 (2018)(PMID:29795370)

Piccirillo AR et al. Histone acetyltransferase CBP is critical for conventional effector and memory T-cell differentiation in mice. J Biol Chem. 294, 2397-2406 (2019) (PMID:30573679)

Xu Y et al. A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy. Theranostics. 9, 3388-3397 (2019)(PMID:31244959)

Yue Yin et al. Simultaneous delivery of DNA vaccine and hydrophobic adjuvant using reducible polyethylenimine-functionalized graphene oxide for activation of dendritic cells

Xu J et al. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nat Nanotechnol. 15, 1043-1052 (2020)(PMID:33139933)

Flow Cytometry

Kos S et al. Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma. PLoS One. 14, e0217762 (2019)(PMID:31150505)

Nguyen QT et al. Poly-γ-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine. Front Immunol. 10, 1604 (2019)(PMID:31354739)

Poupiot J et al. Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Mol Ther Methods Clin Dev. 15, 83-100 (2019)(PMID:31649958)

Lv M et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 30, 966-979 (2020)(PMID:32839553)

产品描述	Anti-EP4 Polyclonal Antibody is a Rabbit antibody targeting EP4. Anti-EP4 Polyclonal Antibody can be used in FCM,WB.
别名	PTGER4, PTGER2, PTGER 4, PTGER 2, Prostanoid EP4 receptor, Prostaglandin E2 receptor EP4 subtype, Prostaglandin E2 receptor, Prostaglandin E Receptor EP4, Prostaglandin E receptor 4 subtype EP4, Prostaglandin E receptor 4, PGE2 receptor EP4 subtype, PGE receptor EP4 subtype, PE2R4, MGC126583, EP4R, EP4, EP 4
Ig Type	IgG
反应种属	Mouse
验证活性	Sample: Lane 1: Mouse Uterus tissue lysates Lane 2: Mouse Small intestine tissue lysates Lane 3: Mouse Kidney tissue lysates Lane 4: Mouse Prostate tissue lysates Primary: Anti-EP4 (TMAB-00621) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 53 kDa Observed band size: 55 kDa
应用	FCM WB
推荐剂量	WB: 1:500-2000; FCM: 2ug/Test
抗体种类	Polyclonal
宿主来源	Rabbit
亚细胞定位	Cell membrane.
组织特异性	High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle.
构建方式	Polyclonal Antibody
纯化方式	Protein A purified
性状	Liquid
缓冲液	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
浓度	1 mg/mL
研究背景	Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.

免疫原	KLH conjugated synthetic peptide: mouse EP4R/Prostaglandin E Receptor EP4
抗原种属	Mouse
基因名称	PTGER4
基因ID	19219
蛋白名称	Prostaglandin E2 receptor EP4 subtype
Uniprot ID	P32240
研究领域	GPCR,Prostaglandins
功能	Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.

文件下载	文件内容	资源说明
	TMAB-00621-Anti-EP4 Polyclonal Antibody	操作手册
	TMAB-00621-Anti-EP4 Polyclonal Antibody相关单页	宣传单页

搜索历史清除全部记录

Anti-EP4 Polyclonal Antibody

产品组分

文件资源

营销中心

注意事项

FAQ